Department of Biotechnology hosts webinar on biomanufacturing of enzymes
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
The State’s PPP model has already mobilised Rs. 150 crore in core infrastructure, while Thermo Fisher has invested Rs. 90 crore in the Bioprocess Design Centre and its co-located Customer Experience Centre
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
Several technologies for hemoglobinopathies are being transferred to commercial partners
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Subscribe To Our Newsletter & Stay Updated